[Elsevier] PL02.06 First-Line Osimertinib + Chemotherapy Versus Osimertinib Monotherapy in EGFRm Advanced NSCLC: FLAURA2 Final Overall Survival

trunghai Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-06-18 11:57
Reward10points

journalㄩJournal of Thoracic Oncology

AuthorsㄩD. Planchard; P.A. Jnne; K. Kobayashi; J.C.-H. Yang; Y. Liu; N. Valdiviezo; T.M. Kim; L. Jiang; H. Kagamu; N. Yanagitani; J. Wang; B. Biswas; A. Poltoratskiy; Y. Neron; C. Rojas; L. Koubkova; C. Escriu; D.A. Ezeife; K. Barrett; M. Albayaty; H. Jiang; C.K. Lee

Published dateㄩ2025-10-

DOIㄩ10.1016/j.jtho.2025.09.015

PDF linkㄩhttps://www.sciencedirect.com/sc ... 556086425010652/pdf

Article linkㄩhttps://doi.org/10.1016/j.jtho.2025.09.015

Article SourceㄩElsevier BV


Remarkㄩ
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Senior Member
  • post

  • reply

  • points

    4190


Daily Top Contributors

Return to the list